- Report
- January 2026
Global
From €4540EUR$4,900USD£3,801GBP
- Report
- January 2026
Global
From €4540EUR$4,900USD£3,801GBP
- Report
- October 2026
- 474 Pages
Global
From €5420EUR$5,850USD£4,538GBP
- Report
- February 2026
- 250 Pages
Global
From €4160EUR$4,490USD£3,483GBP
- Report
- February 2026
- 250 Pages
Global
From €4160EUR$4,490USD£3,483GBP
- Report
- September 2026
- 184 Pages
Global
From €3284EUR$3,545USD£2,750GBP
€3649EUR$3,939USD£3,056GBP
- Report
- September 2026
- 186 Pages
Global
From €3284EUR$3,545USD£2,750GBP
€3649EUR$3,939USD£3,056GBP
- Report
- June 2026
- 160 Pages
Global
From €2593EUR$2,799USD£2,172GBP
€3242EUR$3,499USD£2,714GBP
- Report
- October 2023
- 110 Pages
Global
From €5512EUR$5,950USD£4,616GBP
- Report
- July 2025
- 350 Pages
Global
From €4585EUR$4,949USD£3,839GBP
- Report
- March 2024
- 100 Pages
Europe
From €1390EUR$1,500USD£1,164GBP
- Report
- August 2025
- 150 Pages
Global
From €2928EUR$3,160USD£2,451GBP
€3660EUR$3,950USD£3,064GBP
- Report
- February 2023
- 191 Pages
Global
From €3335EUR$3,600USD£2,793GBP
- Report
- February 2022
- 602 Pages
Europe
From €8334EUR$8,995USD£6,978GBP
- Report
- November 2019
China
From €7407EUR$7,995USD£6,202GBP
The Overactive Bladder (OAB) market is a subset of the Urology and Nephrology industry. OAB is a condition characterized by frequent urination, urgency, and urge incontinence. It is estimated that OAB affects up to 33% of adults worldwide. Treatment options for OAB include lifestyle modifications, medications, and neuromodulation.
The OAB market is expected to grow due to the increasing prevalence of OAB, the introduction of new treatments, and the increasing awareness of the condition. Additionally, the aging population is expected to drive the market growth.
Companies in the OAB market include Allergan, Astellas Pharma, Boston Scientific, Medtronic, and Coloplast. Show Less Read more
